Suppl. Table 2.
Secondary outcomes – intention to treat analysis
| Group SJ (n = 48) | Group DJ (n = 56) | p | ||
|---|---|---|---|---|
| Tolerability / Symptom Questionnaire – Mdn (IQR) | ||||
| LUTS Symptom Score Total | W1 | 6.5 (3–10) | 9 (5–12.75) | 0.080 |
| W4 | 3 (0–6.75) | 6 (2–10) | 0.005 | |
| Lumbar Pain | W1 | 2 (0–4.75) | 2.5 (0–5) | 0.510 |
| W4 | 0 (0–1) | 1 (0–5) | 0.008 | |
| Supra-pubic Pain | W1 | 2 (0–4) | 3 (0–5) | 0.210 |
| W4 | 0 (0–0.75) | 1 (0–4) | 0.004 | |
| Efficacy, n (%) | Group SJ (n = 17) | Group DJ (n = 15) | p | |
| Stone-free rate | 13 (76.5) | 11 (73.3) | 0.840 | |
IQR – interquartile range; Mdn – median; W1 – postoperative week 1; W4 – postoperative week 4